{"disease":{"id":"post-stroke-epilepsy","name":"post stroke epilepsy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05987397","title":"Exploring the Preventive Effect of Mitochondrial Protective Agent Idebenone on Post-stroke Epilepsy","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":2700,"lead_sponsor_name":"Xiangya Hospital of Central South University","has_results":false},{"nct_id":"NCT06812000","title":"Post-stroke Seizure and Epilepsy Following Thrombolytic Therapy","phase":"","overall_status":"COMPLETED","enrollment_count":199,"lead_sponsor_name":"Mazandaran University of Medical Sciences","has_results":false},{"nct_id":"NCT06597084","title":"Anti-epileptogenic Effects of Eslicarbazepine Acetate","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":129,"lead_sponsor_name":"Bial - Portela C S.A.","has_results":true},{"nct_id":"NCT03848273","title":"Post Stroke Epileptic Seizures Risk Forecast","phase":"","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Lviv National Medical University","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}